2281. Ceftolozane–tazobactam (C/T) Treatment Outcomes in Immunocompromised (IC) Patients with Multidrug-Resistant (MDR) Pseudomonas aeruginosa (PA) Infections

door Hart, Delaney E, Gallagher, Jason C, Puzniak, Laura A, Hirsch, Elizabeth B, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2019)

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes

door Hirsch, Elizabeth B, Tam, Vincent H
Gepubliceerd in 2010

1438. Escherichia coli (EC) ST131-H30 Clonal Group is Associated with Antimicrobial Resistance, Illness Severity, Host Compromise, and Non-Cure among Patients with Bacteriuria

door Mahoney, Melanie T, Brigman, Hunter V, Johnston, Brian, Raux, Brian R, Johnson, James R, Hirsch, Elizabeth B, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2019)

2164. Activity of Fosfomycin (FOF) and Frequency of Nonsusceptible Inner Colonies During Susceptibility Testing of an International Collection of Clinical Pseudomonas aeruginosa (P...

door Smith, Elizabeth C, Brigman, Hunter V, Anderson, Jadyn C, Emery, Christopher L, Bias, Tiffany E, Landersdorfer, Cornelia B, Bergen, Phillip J, Hirsch, Elizabeth B, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2019)

Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections

door Giancola, Stephanie E, Mahoney, Monica V, Bias, Tiffany E, Hirsch, Elizabeth B
Gepubliceerd in Ther Clin Risk Manag (2016)

A Multicenter Evaluation of Ceftolozane/Tazobactam Treatment Outcomes in Immunocompromised Patients With Multidrug-Resistant Pseudomonas aeruginosa Infections

door Hart, Delaney E, Gallagher, Jason C, Puzniak, Laura A, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2021)

Activity of Ceftolozane/tazobactam (C/T) and Ceftazidime/avibactam (CZA) against Extended-spectrum Β-lactamase (ESBL)-producing Enterobacteriaceae and Multidrug-resistant (MDR) Pse...

door Hirsch, Elizabeth B, Zucchi, Paola, Cheung, Nicole, Krevolin, Kyle, Emery, Christopher, Bias, Tiffany
Gepubliceerd in Open Forum Infect Dis (2017)

The Activity of Antimicrobial Surfaces Varies by Testing Protocol Utilized

door Campos, Matias D., Zucchi, Paola C., Phung, Ann, Leonard, Steven N., Hirsch, Elizabeth B.
Gepubliceerd in PLoS One (2016)

219. Characteristics Associated with Inappropriate Antibiotic Prescribing in Patients with Asymptomatic Bacteriuria (ASB)

door Bixby, Morgan L, Raux, Brian R, Bhalla, Aakansha, McCoy, Christopher, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2020)

Surface Microbiology of the iPad Tablet Computer and the Potential to Serve as a Fomite in Both Inpatient Practice Settings as Well as Outside of the Hospital Environment

door Hirsch, Elizabeth B., Raux, Brian R., Lancaster, Jason W., Mann, Rachael L., Leonard, Steven N.
Gepubliceerd in 2014

Novel Modeling Framework To Guide Design of Optimal Dosing Strategies for β-Lactamase Inhibitors

door Bhagunde, Pratik, Chang, Kai-Tai, Hirsch, Elizabeth B., Ledesma, Kimberly R., Nikolaou, Michael, Tam, Vincent H.
Gepubliceerd in 2012

133. Creation of an Emergency Department (ED)-Specific Urine Antibiogram and Evaluation of Urinary Tract Infection (UTI) Prescribing Practices at a Tertiary Academic Medical Center

door Broadbent, Eleanor K, Caitlin, Schanz, Boeser, Kimberly D, Mason, Jocelyn, Norton, Laura E, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2020)

In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria

door Hirsch, Elizabeth B., Ledesma, Kimberly R., Chang, Kai-Tai, Schwartz, Michael S., Motyl, Mary R., Tam, Vincent H.
Gepubliceerd in 2012

Volatile metabolic diversity of Klebsiella pneumoniae in nutrient-replete conditions

door Rees, Christiaan A., Nordick, Katherine V., Franchina, Flavio A., Lewis, Alexa E., Hirsch, Elizabeth B., Hill, Jane E.
Gepubliceerd in Metabolomics (2017)

652. Comparison of fosfomycin (FOF) activity and prevalence of subpopulations between Escherichia coli (EC) and Klebsiella pneumoniae (KP) during susceptibility testing

door Anderson, Jadyn C, Krueger, Amanda R, Smith, Elizabeth C, Bixby, Morgan L, Brigman, Hunter V, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2020)

674. Variations in Agreement and Epidemiological Cutoff Value (ECV) between Fosfomycin (FOF) Agar Dilution and Broth Microdilution Using Standard- and High-Inoculum Protocols for K...

door Krueger, Amanda R, Anderson, Jadyn C, Smith, Elizabeth C, Bixby, Morgan L, Brigman, Hunter V, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2020)

Mortality Impact of CLSI Carbapenem Breakpoint Changes in Enterobacteriaceae Bloodstream Infections: a Patient-level Analysis of Published Data

door O’Donnell, J Nicholas, Rhodes, Nathaniel, Biehle, Lauren R, Patel, Twisha, McLaughlin, Milena, Esterly, John, Hirsch, Elizabeth B
Gepubliceerd in Open Forum Infect Dis (2017)

Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics

door Hirsch, Elizabeth B., Zucchi, Paola C., Chen, Alice, Raux, Brian R., Kirby, James E., McCoy, Christopher, Eliopoulos, George M.
Gepubliceerd in Antimicrob Agents Chemother (2016)

Discordance of SHEA/IDSA Clostridium difficile Disease Severity Scale in Solid Organ Transplant Patients

door Lee, Tiffany, McCoy, Christopher, Alonso, Carolyn D, Snyder, Graham M, Rogers, Christin, Richards, Katelyn, Hirsch, Elizabeth B, Mahoney, Monica V
Gepubliceerd in Open Forum Infect Dis (2017)

1330. Development of a Pediatric Emergency Department (ED) Uropathogen Antibiogram and Empiric Urinary Tract Infection (UTI) Treatment Algorithm

door Dass, Akshith M, Broadbent, Eleanor K, Schanz, Caitlin, Louden, Nicole, Hansen, Lizbeth, Hirsch, Elizabeth B, Boeser, Kimberly D, Norton, Laura E
Gepubliceerd in Open Forum Infect Dis (2020)